The Cancer Letter

Inside information on cancer research and drug development

Vol.
39
No.
24
June 14, 2013Jun 14, 2013
DOWNLOAD THE PDF

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

FASEB: Focus on Research Funding, Not PR

MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account